Indicators of amyloid burden in a population-based study of cognitively normal elderly

OBJECTIVES: Secondary prevention trials in subjects with preclinical Alzheimer disease may require documentation of brain amyloidosis. The identification of inexpensive and noninvasive screening variables that can identify individuals who have significant amyloid accumulation would reduce screening...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mielke, Michelle M., Wiste, Heather J., Weigand, Stephen D., Knopman, David S., Lowe, Val J., Roberts, Rosebud O., Geda, Yonas E., Swenson-Dravis, Dana M., Boeve, Bradley F., Senjem, Matthew L., Vemuri, Prashanthi, Petersen, Ronald C., Jack, Clifford R.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2012
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475629/
https://ncbi.nlm.nih.gov/pubmed/22972644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31826e2696
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars